CAS Number: 79517-01-4
EC Number: 616-695-4
Molecular Weight: 1139.3
Chemical Formula: C₅₃H₇₄N₁₀O₁₄S₂
IUPAC Name: acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosa
함량(Assay): 함량 시험(HPLC): 무수물 기준 octreotide acetate 95.0–102.0% 함유하며, 해당 약전 개별 규격 한도에 적합하다.
Purity: HPLC 피크 면적 백분율법으로 순도 98.0% 이상을 확인하며, 각 생산 배치별 품질분석서(CoA)로 검증한다.
불순물 프로파일: 개별 미지 불순물 0.10% 이하, 총 불순물 0.5% 이하, for indications spanning acromegaly, carcinoid syndrome and VIPomas이며, 밸리데이션이 완료된 HPLC/UPLC법으로 관리한다.

기타 정보

추가 설명:

This synthetic octapeptide analogue of naturally occurring somatostatin (CAS 83150-76-9; molecular formula C49H66N10O10S2; molar mass 1019.26 g/mol; sequence H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol acetate salt with a disulfide bond) has a longer duration of action than somatostatin itself and is used for acromegaly, carcinoid syndrome and VIPomas. Octreotide acetate suppresses secretion of gastro-entero-pancreatic peptide hormones and growth hormone release, while also slowing gastrointestinal motility and inhibiting gallbladder contraction.